Clinical Trial Update: Calcineurin Inhibitor Based Immunosuppression Withdrawal [NA]

View source ↗

Summary

A pediatric renal transplant trial evaluating withdrawal of calcineurin inhibitor–based immunosuppression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Pediatric Nephrology of Alabama | Conditions: Renal Transplant | NA | Status: COMPLETED